News

A Bay Area woman given just two years to live after being diagnosed with lung cancer has lived for eight. Statistics show she is part of a group of young never-smoking Asian American women who are ...
Researchers discovered a distinct plasma biomarker signature involving proteins like CCL3 and IL-18, associated with cell death, lung injury, and platelet activation. These findings offer ...
Arsenal manager Mikel Arteta says midfielder Jorginho is "recovering well" from a lung injury and might play again this season. The 33-year-old's last appearance came on 12 April when he was ...
Kentucky. After he retired in 1997, he was diagnosed with black lung, a common respiratory illness caused by breathing coal and other kinds of dust. He filed for benefits with the federal ...
“The AI-enabled CXRs revealed important findings, including lung nodules at high risk for cancer in nearly 50,000 people – prompting their referral for further testing and possible diagnosis ...
May 8, 2025 — A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve ...
The Trump administration plans to terminate federal workers focused on preventing and responding to work-related illnesses, including "black lung" disease in coal miners, according to an internal ...
Apr. 7, 2025 — As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new ... Apr. 2, 2025 — Lung cancer ...
Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...
Despite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just drug research. The new Lung Ambition Alliance – launched in July ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).
Pyoderma gangrenosum (PG) is a neutrophilic inflammatory dermatosis caused by the dysregulation of innate and adaptive immune components in genetically predisposed individuals. 1 In Latin America, ...